Project Grant R01GM157610

Award Date 9/10/24
Completion Date 8/31/27
Dollars Obligated $180K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
New Brunswick, NJ 08901, USA
Similar Awards
This federal Project Grant award, with a total funding amount of $336,070.00, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The award, effective September 1, 2024, supports research conducted by Rutgers, The State University of New Jersey, to define and manipulate the gene regulatory networks that dictate the transition through senescence states. The research program aims to generate...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $378,714 to the Rochester Institute of Technology (RIT) to develop novel bio-statistical graph learning strategies for structural characterization of large-scale disease pathways and systematic biomedical data analytics. The goal is to leverage both node features and topological information in protein-protein...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will support research into the molecular mechanisms of ribosome biogenesis by force-producing enzymes. The $392,500 award to Rutgers, The State University of New Jersey will fund a 5-year project focused on characterizing how ATP-driven mechanoenzymes sequentially convert ribosomal precursors into mature ribosomes. Key activities...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $360,247 to Rutgers, The State University of New Jersey to explore the mechanisms of Type III CRISPR-Cas antiviral signaling in microbes. The research aims to investigate how CRISPR-associated signaling effectors, including nucleases and membrane proteins, are regulated by cyclic nucleotide second messengers to mediate...
The National Institute of General Medical Sciences (NIGMS) has awarded a $492,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Princeton University. The grant, which runs from Sep 1, 2024 to Aug 31, 2029, supports research aimed at accessing previously hidden sources of microbial natural products and investigating their structures, functions, therapeutic uses, and biosynthetic pathways. Key objectives include eliciting cryptic metabolites from...
The National Institute of General Medical Sciences (NIGMS) awarded a $243,840 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Pittsburgh. The project, titled "An Effective Statistical Inference Framework to Develop Innovative Compensations for Protein Mutations," aims to develop quantitative methods for predicting the impact of protein mutations and identifying compensatory mutations that can restore normal protein...
The National Institute of General Medical Sciences (NIGMS), through its Biomedical Research and Research Training program (CFDA 93.859), awarded a $355,584 Project Grant to the New Mexico Institute of Mining and Technology (New Mexico Tech) on August 18, 2023. This funding will support research to determine the biochemical basis and functional implications of the interaction between the proteins XRN2 and DDX23, and explore their cooperative role in regulating RNA-DNA hybrid structures...
This $300,477 federal Project Grant award was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The award will support a 5-year research project focused on investigating the molecular regulation of cell protrusion function in 3D environments. The research aims to develop computational algorithms based on computational geometry to reconstruct plasma membrane organization from 3D microscopy images and...
This federal Project Grant award of $123,737.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to advance drug discovery for protein domains containing intrinsically disordered regions. The award was granted to the Regents of the University of Michigan, a prominent U.S. state government-owned educational institution, with a performance period from October 1, 2024 to April 30, 2025. The NIGMS...
The National Institute of General Medical Sciences (NIGMS) awarded a $440,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the Sloan-Kettering Institute for Cancer Research in New York. The 5-year grant, awarded on February 3, 2025, supports advanced research to decode the ubiquitin and autophagy signaling networks, which are essential cellular processes involved in proteome homeostasis. The research program combines expertise in quantitative mass spectrometry,...

The federal Project Grant award R01GM157610 for $179,703.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant supports a research project titled "DISEASE GENE DISCOVERY BY MARKOVIAN GENE NETWORK" to be conducted by Rutgers, The State University in New Brunswick, NJ. The project aims to advance understanding in areas such as molecular biology, genetics, biochemistry, and biomedical technologies, with the goal of increasing knowledge about biological processes and laying the groundwork for improvements in disease diagnosis, treatment, and prevention. The grant period runs from Sep 10, 2024 to Aug 31, 2027.

Generated 7/1/25, 2:16 AM